EBMT 2024 | The consequences of regulatory changes on access to devices and reagents needed for graft processing
Christian Chabannon
• 16 Apr 2024
Christian Chabannon, MD, PhD, Institut Paoli Calmettes, Marseille, France, comments on his talk which discussed the consequences of regulatory changes on access to devices and reagents needed for graft processing. It is important for the EBMT Legal & Regulatory Affairs Committee to understand how regulations develop over time and how this may impact access to transplant and advanced therapies. This interview took place at the 50th Annual Meeting of the EBMT in Glasgow, Scotland.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
